Gregory Filice

Excess Costs and Utilization Associated with Methicillin Resistance for Patients with Staphylococcus aureus Infection

OBJECTIVE To determine differences in healthcare costs between cases of methicillin-susceptible Staphylococcus aureus (MSSA) infection and methicillin-resistant S. aureus (MRSA) infection in adults. DESIGN Retrospective study of all cases of S. aureus infection. SETTING Department of Veterans Affairs hospital and associated clinics. PATIENTS There were 390 patients with MSSA infections and 335 patients with MRSA infections. METHODS We used medical records, accounting systems, and interviews to identify services rendered and costs for Minneapolis Veterans Affairs Medical Center patients with S. aureus infection with onset during the period from January 1, 2004, through June 30, 2006. We used regression analysis to adjust for patient characteristics. RESULTS Median 6-month unadjusted costs for patients infected with MRSA were

Comparative effectiveness of Clostridium difficile treatments: a systematic review

34,657, compared with

Infection in the myelodysplastic syndromes

15,923 for patients infected with MSSA. Patients with MRSA infection had more comorbidities than patients with MSSA infection (mean Charlson index 4.3 vs 3.2; P < .001). For patients with Charlson indices of 3 or less, mean adjusted 6-month costs derived from multivariate analysis were

Neuroleptic Malignant Syndrome Associated with Olanzapine

51,252 (95% CI,

Antimicrobial stewardship in outpatient settings: a systematic review.

46,041-

Antimicrobial Stewardship Programs in Inpatient Hospital Settings: A Systematic Review

56,464) for MRSA infection and

Antigen Detection in the Diagnosis of Invasive Aspergillosis: Utility in Controlled, Blinded Trials

30,158 (95% CI,

The role of preschool children and day-care centers in the spread of shigellosis in urban communities.

27,092-

Diagnosis and Outcome of 100 Consecutive Patients with Extreme Granulocytic Leukocytosis

33,225) for MSSA infection. For patients with Charlson indices of 4 or more, mean adjusted costs were

Infectious Disease Consultation for Staphylococcus aureus Bacteremia Improves Patient Management and Outcomes.

84,436 (95% CI,